Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **30S ribosomal decoding A-site** is a highly conserved region within the small (30S) subunit of the prokaryotic ribosome, chiefly responsible for monitoring base-pairing between mRNA codons and tRNA anticodons to ensure faithful translation[1][6]. This site, located within the 16S ribosomal RNA component, plays a central role in the decoding process during protein synthesis by selecting correct aminoacyl-tRNAs that match the mRNA codon, with critical involvement of nucleotides A1492 and A1493[1][6]. The A-site is a major target for several classes of antibiotics (including aminoglycosides and spectinomycin) that exert their antibacterial effect by binding to this region, thereby disrupting the accuracy of translation and ultimately inhibiting bacterial growth[1][6]. The structural integrity and conformational dynamics of the A-site are also critical for its function and for mediating interactions with antibiotics. Resistance arises through mutations that alter antibiotic binding without compromising essential decoding functions[1][6]. This target is widely exploited in the development of antibacterial agents due to its key role in the fidelity of protein biosynthesis and its structural and functional divergence from the eukaryotic ribosome[1][6].
Inhibition of protein synthesis by binding to the 30S A-site and disrupting decoding fidelity (causing misreading or premature termination) - Stabilization of tRNA–mRNA mismatches leading to bacteriostatic or bactericidal effects
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 30S ribosomal decoding A-site (30S A-site).